Wu X, et al., 2015

Researchers in this study wanted to find a noninvasive way to detect early breast cancer, including pre-cancerous conditions like ductal carcinoma in situ (DCIS). Early detection is critical for improving outcomes, but current screening methods do not always identify cancer at its earliest stages.

To investigate this, the researchers analyzed cell-free DNA in blood samples, focusing specifically on telomeres, which are protective DNA sequences at the ends of chromosomes. Telomeres naturally shorten as cells divide, and abnormal changes in telomere length have been linked to cancer development.

The researchers found that women with early-stage breast cancer or pre-cancerous conditions had lower levels of telomeric DNA in their blood compared to healthy individuals. This suggests that cancer-related changes in cells may release altered DNA into the bloodstream, which can be detected through a blood test.

Overall, the study shows that measuring telomere-related DNA in blood may serve as a potential early detection tool, helping identify breast cancer before it becomes more advanced.

Full-Text Journal Article PubMed

What did they study?

• In this study, researchers examined whether blood-based DNA markers could help detect early breast cancer. They investigated:
• Cell-free DNA circulating in the bloodstream
• Telomere-related DNA (protective chromosome end sequences)
• Differences between:
  • Healthy individuals
  • Patients with early-stage breast cancer
  • Patients with pre-cancerous conditions (DCIS)
• Whether these DNA patterns could serve as early detection markers

What did they find?

• Telomeric DNA levels were lower in cancer patients: Individuals with early breast cancer or DCIS showed reduced levels of telomere-related DNA in blood.
• Changes were detectable in early stages: Differences were observed even before cancer became invasive.
• Blood-based testing shows promise: These findings suggest a potential noninvasive screening method.
• Telomere changes reflect underlying biology: Altered telomere patterns may indicate early cellular damage or instability.
• This approach could complement existing screening tools.

Why is this study important?

This study is important because it suggests that a simple blood test could help detect breast cancer at its earliest stages, when treatment is most effective. By identifying changes in telomere-related DNA, researchers provide a potential tool for early diagnosis and monitoring.

This approach could improve screening, especially for individuals at higher risk, and reduce the need for more invasive procedures. It also highlights how molecular changes in normal cells can signal the earliest steps of cancer development.

Full citation

Wu X,Tanaka H Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.. Oncotarget 2015 Oct; 6 (30). PMID:26356673.